Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Rigel Pharmaceuticals Inc. (RIGL)

2.02   -0.03 (-1.46%) 05-23 16:00
Open: 2.14 Pre. Close: 2.16
High: 2.17 Low: 2.04
Volume: 1,653,550 Market Cap: 338M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 2.174 - 2.187 2.187 - 2.2
Low: 2.007 - 2.02 2.02 - 2.034
Close: 1.996 - 2.018 2.018 - 2.043

Technical analysis

as of: 2019-05-23 4:27:58 PM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 2.66     One year: 2.83
Support: Support1: 2.04    Support2: 1.70
Resistance: Resistance1: 2.27    Resistance2: 2.42
Pivot: 2.19
Moving Average: MA(5): 2.08     MA(20): 2.21
MA(100): 2.29     MA(250): 2.70
MACD: MACD(12,26): -0.07     Signal(9): -0.06
Stochastic oscillator: %K(14,3): 11.40     %D(3): 11.88
RSI: RSI(14): 37.12
52-week: High: 3.98  Low: 1.96  Change(%): -48.9
Average Vol(K): 3-Month: 165381  10-Days: 176673

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
RIGL has closed above bottom band by 7.2%. Bollinger Bands are 3.8% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Fri, 17 May 2019 15:19:41 Z
Rigel Initiates Enrollment in Pivotal Blood Disorder Study

Wed, 08 May 2019 06:15:01 Z
Rigel Pharmaceuticals Inc (RIGL) Q1 2019 Earnings Call Transcript

Wed, 08 May 2019 00:14:04 Z
Rigel Pharmaceuticals (RIGL) Reports Q1 Loss, Tops Revenue Estimates

Wed, 10 Apr 2019 02:05:48 Z
Here's Why Rigel Pharmaceuticals Gained 17.3% in March

Fri, 01 Mar 2019 16:08:48 Z
Rigel Pharmaceuticals (RIGL) Q4 2018 Earnings Conference Call Transcript

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 167.19
Shares Float (M) 166.52
% Held by Insiders
% Held by Institutions
Shares Short (K)
Shares Short P. Month (K)

Stock Financials

EPS -0.450
EPS Est. Current Year -0.600
EPS Est. Next Year -0.430
EPS Est. Next Quarter -0.150
Forward EPS -0.470
Book Value (p.s.) 3.840
PEG Ratio -0.08
Profit Margin
Operating Margin -116.09
Return on Assets (ttm) -48.5
Return on Equity (ttm) -75.8
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M) -36.00
Levered Free Cash Flow (M) -41.46

Stock Valuations

P/E -4.49
P/E Growth Ratio -0.01
P/BV 0.53
P/S 993305344.00
P/CF -9.38

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.